{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:17:07Z","timestamp":1792513027584,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Shuren University Basic Scientific Research Special Funds","award":["2024XZ011"],"award-info":[{"award-number":["2024XZ011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04678-8","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:41:25Z","timestamp":1760013685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Stem cell therapy for myocardial infarction and atherosclerosis: mechanisms, challenges, and future directions"],"prefix":"10.1186","volume":"16","author":[{"given":"Xingchen","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"1","key":"4678_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, et al. Atherosclerosis Nat Reviews Disease Primers. 2019;5(1):56.","journal-title":"Atherosclerosis Nat Reviews Disease Primers"},{"issue":"6","key":"4678_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00059-020-04969-1","volume":"45","author":"H Thiele","year":"2020","unstructured":"Thiele H, Zahn R. [Acute myocardial infarction-actual issues]. Herz. 2020;45(6):507\u20138.","journal-title":"Herz"},{"issue":"25","key":"4678_CR3","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk Factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"4678_CR4","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1056\/NEJMoa1311890","volume":"371","author":"S Yusuf","year":"2014","unstructured":"Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. 2014;371(9):818\u201327.","journal-title":"N Engl J Med"},{"key":"4678_CR5","doi-asserted-by":"publisher","first-page":"133143","DOI":"10.1016\/j.ijcard.2025.133143","volume":"428","author":"L Alhuneafat","year":"2025","unstructured":"Alhuneafat L, Al Ta\u2019ani O, Arriola-Montenegro J, Al-Ajloun YA, Naser A, Chaponan-Lavalle A, et al. The burden of cardiovascular disease in Latin America and the Caribbean, 1990\u20132019: an analysis of the global burden of disease study. Int J Cardiol. 2025;428:133143.","journal-title":"Int J Cardiol"},{"issue":"9","key":"4678_CR6","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.3390\/cells10092319","volume":"10","author":"MAM Aboul-Soud","year":"2021","unstructured":"Aboul-Soud MAM, Alzahrani AJ, Mahmoud A. Induced pluripotent stem cells (iPSCs)-Roles in regenerative Therapies, disease modelling and drug screening. Cells. 2021;10(9):2319.","journal-title":"Cells"},{"issue":"1","key":"4678_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-024-04123-2","volume":"16","author":"H Rayat Pisheh","year":"2025","unstructured":"Rayat Pisheh H, Sani M. Mesenchymal stem cells derived exosomes: a new era in cardiac regeneration. Stem Cell Res Ther. 2025;16(1):1\u201321.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"4678_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1089\/ten.teb.2023.0080","volume":"30","author":"CSP Soares","year":"2024","unstructured":"Soares CSP, Ribeiro MHL. Induced pluripotent stem Cell-Derived cardiomyocytes: from regulatory status to clinical translation. Tissue Eng Part B-Reviews. 2024;30(4):12.","journal-title":"Tissue Eng Part B-Reviews"},{"issue":"20","key":"4678_CR9","doi-asserted-by":"publisher","first-page":"7701","DOI":"10.3390\/ijms21207701","volume":"21","author":"A Mancuso","year":"2020","unstructured":"Mancuso A, Barone A, Cristiano MC, Cianflone E, Fresta M, Paolino D. Cardiac stem Cell-Loaded delivery systems: A new challenge for myocardial tissue regeneration. Int J Mol Sci. 2020;21(20):7701.","journal-title":"Int J Mol Sci"},{"key":"4678_CR10","doi-asserted-by":"publisher","first-page":"103253","DOI":"10.1016\/j.scr.2023.103253","volume":"73","author":"SK Maierhof","year":"2023","unstructured":"Maierhof SK, Schinke C, Cernoch J, Hew L, Bruske LP, Fernandez Vallone V, et al. Generation of an NCS1 gene knockout human induced pluripotent stem cell line using CRISPR\/Cas9. Stem Cell Res. 2023;73:103253.","journal-title":"Stem Cell Res"},{"issue":"1","key":"4678_CR11","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1186\/s12891-021-04617-7","volume":"22","author":"H Zhao","year":"2021","unstructured":"Zhao H, Shen S, Zhao L, Xu Y, Li Y, Zhuo N. 3D printing of dual-cell delivery titanium alloy scaffolds for improving osseointegration through enhancing angiogenesis and osteogenesis. BMC Musculoskelet Disord. 2021;22(1):734.","journal-title":"BMC Musculoskelet Disord"},{"issue":"8","key":"4678_CR12","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1007\/s12015-022-10429-6","volume":"18","author":"NS Mabotuwana","year":"2022","unstructured":"Mabotuwana NS, Rech L, Lim J, Hardy SA, Murtha LA, Rainer PP, et al. Paracrine factors released by stem cells of mesenchymal origin and their effects in cardiovascular disease: A systematic review of Pre-clinical studies. Stem Cell Rev Rep. 2022;18(8):2606\u201328.","journal-title":"Stem Cell Rev Rep"},{"key":"4678_CR13","doi-asserted-by":"publisher","first-page":"114817","DOI":"10.1016\/j.biopha.2023.114817","volume":"163","author":"Y Pan","year":"2023","unstructured":"Pan Y, Wu W, Jiang X, Liu Y. Mesenchymal stem cell-derived exosomes in cardiovascular and cerebrovascular diseases: from mechanisms to therapy. Biomed Pharmacother. 2023;163:114817.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"4678_CR14","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1159\/000492704","volume":"48","author":"P Muller","year":"2018","unstructured":"Muller P, Lemcke H, David R. Stem cell therapy in heart Diseases - cell Types, mechanisms and improvement strategies. Cell Physiol Biochem. 2018;48(6):2607\u201355.","journal-title":"Cell Physiol Biochem"},{"issue":"9","key":"4678_CR15","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.3390\/ijms25094937","volume":"25","author":"A Klimczak","year":"2024","unstructured":"Klimczak A. Mesenchymal Stem\/Progenitor cells and their derivates in tissue Regeneration-Part II. Int J Mol Sci. 2024;25(9):4937.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4678_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/ajco.13969","volume":"20","author":"A TomyTomcy","year":"2024","unstructured":"TomyTomcy A, Sindhu ER. Mesenchymal stem cells- an excellent therapeutic agent for cancer. Asia Pac J Clin Oncol. 2024;20(1):7\u201315.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"4","key":"4678_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3904\/kjim.2013.28.4.387","volume":"28","author":"N Kim","year":"2013","unstructured":"Kim N, Cho SG. Clinical applications of mesenchymal stem cells. Korean J Intern Med. 2013;28(4):387\u2013402.","journal-title":"Korean J Intern Med"},{"issue":"11","key":"4678_CR18","doi-asserted-by":"publisher","first-page":"e48699","DOI":"10.1371\/journal.pone.0048699","volume":"7","author":"S Nagata","year":"2012","unstructured":"Nagata S, Hirano K, Kanemori M, Sun LT, Tada T. Self-renewal and pluripotency acquired through somatic reprogramming to human cancer stem cells. PLoS ONE. 2012;7(11):e48699.","journal-title":"PLoS ONE"},{"key":"4678_CR19","doi-asserted-by":"publisher","first-page":"1472103","DOI":"10.3389\/fcell.2024.1472103","volume":"12","author":"ZS Razavi","year":"2024","unstructured":"Razavi ZS, Farokhi S, Mahmoudvand G, Karimi-Rouzbahani A, Farasati-Far B, Tahmasebi-Ghorabi S, et al. Stem cells and bio scaffolds for the treatment of cardiovascular diseases: new insights. Front Cell Dev Biol. 2024;12:1472103.","journal-title":"Front Cell Dev Biol"},{"issue":"10466","key":"4678_CR20","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(24)01764-1","volume":"404","author":"T Soma","year":"2024","unstructured":"Soma T, Oie Y, Takayanagi H, Matsubara S, Yamada T, Nomura M, et al. Induced pluripotent stem-cell-derived corneal epithelium for transplant surgery: a single-arm, open-label, first-in-human interventional study in Japan. Lancet (London England). 2024;404(10466):1929\u201339.","journal-title":"Lancet (London England)"},{"issue":"14","key":"4678_CR21","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1093\/jxb\/erae264","volume":"75","author":"J Wittmer","year":"2024","unstructured":"Wittmer J, Heidstra R. Appreciating animal induced pluripotent stem cells to shape plant cell reprogramming strategies. J Exp Bot. 2024;75(14):4373\u201393.","journal-title":"J Exp Bot"},{"issue":"5","key":"4678_CR22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/biom11050699","volume":"11","author":"A Fus-Kujawa","year":"2021","unstructured":"Fus-Kujawa A, Mendrek B, Trybus A, Bajdak-Rusinek K, Stepien KL, Sieron AL. Potential of induced pluripotent stem cells for use in gene therapy: History, molecular Bases, and medical perspectives. Biomolecules. 2021;11(5):699.","journal-title":"Biomolecules"},{"issue":"7","key":"4678_CR23","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.ymthe.2018.02.026","volume":"26","author":"A Oikonomopoulos","year":"2018","unstructured":"Oikonomopoulos A, Kitani T, Wu JC. Pluripotent stem cell-Derived cardiomyocytes as a platform for cell therapy applications: progress and hurdles for clinical translation. Mol Ther. 2018;26(7):1624\u201334.","journal-title":"Mol Ther"},{"issue":"7","key":"4678_CR24","doi-asserted-by":"publisher","first-page":"11099","DOI":"10.1021\/acsnano.1c00628","volume":"15","author":"J Yao","year":"2021","unstructured":"Yao J, Huang K, Zhu D, Chen T, Jiang Y, Zhang J, et al. A minimally invasive exosome spray repairs heart after myocardial infarction. ACS Nano. 2021;15(7):11099\u2013111.","journal-title":"ACS Nano"},{"issue":"1","key":"4678_CR25","doi-asserted-by":"publisher","first-page":"8183","DOI":"10.1038\/s41467-023-43312-0","volume":"14","author":"I Fernandes","year":"2023","unstructured":"Fernandes I, Funakoshi S, Hamidzada H, Epelman S, Keller G. Modeling cardiac fibroblast heterogeneity from human pluripotent stem cell-derived epicardial cells. Nat Commun. 2023;14(1):8183.","journal-title":"Nat Commun"},{"issue":"1","key":"4678_CR26","doi-asserted-by":"publisher","first-page":"10041","DOI":"10.1038\/s41598-019-46407-1","volume":"9","author":"KI Mentkowski","year":"2019","unstructured":"Mentkowski KI, Lang JK. Exosomes engineered to express a cardiomyocyte binding peptide demonstrate improved cardiac retention in vivo. Sci Rep. 2019;9(1):10041.","journal-title":"Sci Rep"},{"issue":"6","key":"4678_CR27","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.3390\/cells9061558","volume":"9","author":"E Cianflone","year":"2020","unstructured":"Cianflone E, Torella M, Biamonte F, De Angelis A, Urbanek K, Costanzo FS, et al. Targeting cardiac stem cell senescence to treat cardiac aging and disease. Cells. 2020;9(6):1558.","journal-title":"Cells"},{"key":"4678_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.yjmcc.2023.12.001","volume":"187","author":"Y Soma","year":"2024","unstructured":"Soma Y, Tani H, Morita-Umei Y, Kishino Y, Fukuda K, Tohyama S. Pluripotent stem cell-based cardiac regenerative therapy for heart failure. J Mol Cell Cardiol. 2024;187:90\u2013100.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"4678_CR29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12964-023-01227-9","volume":"21","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang M, Yu Y, Li C, Zhang C. Advances in the study of exosomes derived from mesenchymal stem cells and cardiac cells for the treatment of myocardial infarction. Cell Commun Signal. 2023;21(1):202.","journal-title":"Cell Commun Signal"},{"key":"4678_CR30","doi-asserted-by":"publisher","first-page":"8031718","DOI":"10.1155\/2018\/8031718","volume":"2018","author":"REB Fitzsimmons","year":"2018","unstructured":"Fitzsimmons REB, Mazurek MS, Soos A, Simmons CA. Mesenchymal Stromal\/Stem cells in regenerative medicine and tissue engineering. Stem Cells Int. 2018;2018:8031718.","journal-title":"Stem Cells Int"},{"key":"4678_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fcell.2020.00036","volume":"8","author":"C Fan","year":"2020","unstructured":"Fan C, Zhang E, Joshi J, Yang J, Zhang J, Zhu W. Utilization of human induced pluripotent stem cells for cardiac repair. Front Cell Dev Biol. 2020;8:36.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"4678_CR32","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41419-022-05034-x","volume":"13","author":"M Kou","year":"2022","unstructured":"Kou M, Huang L, Yang J, Chiang Z, Chen S, Liu J, et al. Mesenchymal stem cell-derived extracellular vesicles for Immunomodulation and regeneration: a next generation therapeutic tool? Cell Death Dis. 2022;13(7):580.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4678_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13287-023-03345-0","volume":"14","author":"C Zhou","year":"2023","unstructured":"Zhou C, Zhang B, Yang Y, Jiang Q, Li T, Gong J, et al. Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing. Stem Cell Res Ther. 2023;14(1):107.","journal-title":"Stem Cell Res Ther"},{"key":"4678_CR34","doi-asserted-by":"publisher","first-page":"e46563","DOI":"10.7554\/eLife.46563","volume":"8","author":"L Laplane","year":"2019","unstructured":"Laplane L, Solary E. Towards a classification of stem cells. Elife. 2019;8:e46563.","journal-title":"Elife"},{"issue":"4","key":"4678_CR35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1161\/CIRCULATIONAHA.124.072411","volume":"152","author":"Q Wang","year":"2025","unstructured":"Wang Q, Ismahil MA, Zhu Y, Rokosh G, Hamid T, Zhou G, et al. CD206(+)IL-4R\u03b1(+) macrophages are drivers of adverse cardiac remodeling in ischemic cardiomyopathy. Circulation. 2025;152(4):257\u201373.","journal-title":"Circulation"},{"key":"4678_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2025.04.003","volume":"280","author":"M Holthaus","year":"2025","unstructured":"Holthaus M, Xiong X, Eghbalzadeh K, Gro\u00dfmann C, Gei\u00dfen S, Piontek F, et al. Loss of peptidylarginine deiminase 4 mitigates maladaptive cardiac remodeling after myocardial infarction through Inhibition of inflammatory and profibrotic pathways. Transl Res. 2025;280:1\u201316.","journal-title":"Transl Res"},{"key":"4678_CR37","doi-asserted-by":"publisher","first-page":"1581282","DOI":"10.3389\/fphys.2025.1581282","volume":"16","author":"JQ Kwong","year":"2025","unstructured":"Kwong JQ, Correll RN, Liu Q, Editorial. Cell death programs in the pathogenesis of heart disease. Front Physiol. 2025;16:1581282.","journal-title":"Front Physiol"},{"issue":"5\u20136","key":"4678_CR38","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1007\/s10495-025-02108-x","volume":"30","author":"SA Dabravolski","year":"2025","unstructured":"Dabravolski SA, Kalmykov VA, Maksaeva AO, Rozhkova UV, Lapshina KO, Orekhov AN. Necroptosis in myocardial ischaemia-reperfusion injury: current update on mechanisms, therapeutic targets, and translational potential. Apoptosis. 2025;30(5\u20136):1216\u201334.","journal-title":"Apoptosis"},{"key":"4678_CR39","doi-asserted-by":"publisher","first-page":"151920","DOI":"10.1016\/j.bbrc.2025.151920","volume":"768","author":"R Wang","year":"2025","unstructured":"Wang R, Liu L, Han F, Ma Q, He H. Exosomes derived from human umbilical cord mesenchymal stem cells can reverse ventricular remodeling and improve long-term cardiac function after acute myocardial infarction. Biochem Biophys Res Commun. 2025;768:151920.","journal-title":"Biochem Biophys Res Commun"},{"key":"4678_CR40","doi-asserted-by":"publisher","first-page":"637239","DOI":"10.3389\/fcell.2021.637239","volume":"9","author":"Q Li","year":"2021","unstructured":"Li Q, Hou H, Li M, Yu X, Zuo H, Gao J, et al. CD73(+) mesenchymal stem cells ameliorate myocardial infarction by promoting angiogenesis. Front Cell Dev Biol. 2021;9:637239.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"4678_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12015-022-10432-x","volume":"19","author":"H Li","year":"2023","unstructured":"Li H, Gu J, Sun X, Zuo Q, Li B, Gu X. Isolation of swine bone marrow Lin-\/CD45-\/CD133\u2009+\u2009Cells and Cardio-protective effects of its exosomes. Stem Cell Rev Rep. 2023;19(1):213\u201329.","journal-title":"Stem Cell Rev Rep"},{"issue":"2","key":"4678_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/CIRCRESAHA.124.325562","volume":"136","author":"Y Wei","year":"2025","unstructured":"Wei Y, Walcott G, Nguyen T, Geng X, Guragain B, Zhang H, et al. Follistatin from hiPSC-Cardiomyocytes promotes myocyte proliferation in pigs with postinfarction LV remodeling. Circ Res. 2025;136(2):161\u201376.","journal-title":"Circ Res"},{"issue":"1","key":"4678_CR43","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s13287-024-03899-7","volume":"15","author":"Y Chang","year":"2024","unstructured":"Chang Y, Bai R, Zhang Y, Lu W-j, Ma S, Zhu M, et al. SMYD1 modulates the proliferation of multipotent cardiac progenitor cells derived from human pluripotent stem cells during myocardial differentiation through GSK3\u03b2\/\u03b2-catenin&ERK signaling. Stem Cell Res Ther. 2024;15(1):350.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4678_CR44","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1038\/s41598-025-87885-w","volume":"15","author":"J Iida","year":"2025","unstructured":"Iida J, Kotani K, Murata K, Hakamada K, Maihemuti W, Mandai Y, et al. Retention of locally injected human iPS cell-derived cardiomyocytes into the myocardium using hydrolyzed gelatin. Sci Rep. 2025;15(1):4635.","journal-title":"Sci Rep"},{"issue":"8","key":"4678_CR45","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1007\/s11010-025-05285-0","volume":"480","author":"SA Dabravolski","year":"2025","unstructured":"Dabravolski SA, Popov MA, Utkina AS, Babayeva GA, Maksaeva AO, Sukhorukov VN, et al. Preclinical and mechanistic perspectives on adipose-derived stem cells for atherosclerotic cardiovascular disease treatment. Mol Cell Biochem. 2025;480(8):4647\u201370.","journal-title":"Mol Cell Biochem"},{"key":"4678_CR46","doi-asserted-by":"publisher","first-page":"110298","DOI":"10.1016\/j.biopha.2020.110298","volume":"128","author":"X Dou","year":"2020","unstructured":"Dou X, Zhou Z, Ren R, Xu M. Apigenin, flavonoid component isolated from Gentiana veitchiorum flower suppresses the oxidative stress through LDLR-LCAT signaling pathway. Biomed Pharmacother. 2020;128:110298.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"4678_CR47","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/sctm.20-0141","volume":"9","author":"G Liao","year":"2020","unstructured":"Liao G, Zheng K, Shorr R, Allan DS. Human endothelial colony-forming cells in regenerative therapy: A systematic review of controlled preclinical animal studies. Stem Cells Translational Med. 2020;9(11):1344\u201352.","journal-title":"Stem Cells Translational Med"},{"issue":"6","key":"4678_CR48","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.7150\/thno.47354","volume":"11","author":"Z Han","year":"2021","unstructured":"Han Z, Wang X, Xu Z, Cao Y, Gong R, Yu Y, et al. ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1. Theranostics. 2021;11(6):3000\u201316.","journal-title":"Theranostics"},{"issue":"1","key":"4678_CR49","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12672-023-00704-4","volume":"14","author":"C Zhou","year":"2023","unstructured":"Zhou C, Huang Y-Q, Da M-X, Jin W-L, Zhou F-H. Adipocyte-derived extracellular vesicles: bridging the communications between obesity and tumor microenvironment. Discover Oncol. 2023;14(1):92.","journal-title":"Discover Oncol"},{"issue":"12","key":"4678_CR50","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1161\/CIRCRESAHA.117.311080","volume":"120","author":"Y Yoshida","year":"2017","unstructured":"Yoshida Y, Yamanaka S. Induced pluripotent stem cells 10 years later: for cardiac applications. Circ Res. 2017;120(12):1958\u201368.","journal-title":"Circ Res"},{"issue":"6","key":"4678_CR51","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.cell.2011.01.032","volume":"144","author":"RA Young","year":"2011","unstructured":"Young RA. Control of the embryonic stem cell state. Cell. 2011;144(6):940\u201354.","journal-title":"Cell"},{"issue":"22","key":"4678_CR52","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1158\/0008-5472.CAN-16-1311","volume":"76","author":"AK Singh","year":"2016","unstructured":"Singh AK, McGuirk JP. Allogeneic stem cell transplantation: A historical and scientific overview. Cancer Res. 2016;76(22):6445\u201351.","journal-title":"Cancer Res"},{"issue":"4","key":"4678_CR53","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/stem.2807","volume":"36","author":"SP Atkinson","year":"2018","unstructured":"Atkinson SP. A preview of selected Articles - April 2018. Stem Cells. 2018;36(4):471\u20133.","journal-title":"Stem Cells"},{"key":"4678_CR54","doi-asserted-by":"publisher","first-page":"101810","DOI":"10.1016\/j.scr.2020.101810","volume":"45","author":"H Main","year":"2020","unstructured":"Main H, Hedenskog M, Acharya G, Hovatta O, Lanner F. Karolinska Institutet human embryonic stem cell bank. Stem Cell Res. 2020;45:101810.","journal-title":"Stem Cell Res"},{"issue":"7","key":"4678_CR55","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1253\/circj.CJ-18-1179","volume":"83","author":"T Yagyu","year":"2019","unstructured":"Yagyu T, Yasuda S, Nagaya N, Doi K, Nakatani T, Satomi K, et al. Long-Term results of intracardiac mesenchymal stem cell transplantation in patients with cardiomyopathy. Circ J. 2019;83(7):1590\u20139.","journal-title":"Circ J"},{"issue":"1","key":"4678_CR56","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1186\/s12967-024-05816-1","volume":"22","author":"T Kawamura","year":"2024","unstructured":"Kawamura T, Yoshioka D, Kawamura A, Misumi Y, Taguchi T, Mori D, et al. Safety and therapeutic potential of allogeneic adipose-derived stem cell spray transplantation in ischemic cardiomyopathy: a phase I clinical trial. J Translational Med. 2024;22(1):1091.","journal-title":"J Translational Med"},{"issue":"12","key":"4678_CR57","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/eurheartj\/ehu192","volume":"36","author":"P Menasch\u00e9","year":"2014","unstructured":"Menasch\u00e9 P, Vanneaux V, Fabreguettes J-R, Bel A, Tosca L, Garcia S, et al. Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience. Eur Heart J. 2014;36(12):743\u201350.","journal-title":"Eur Heart J"},{"issue":"4","key":"4678_CR58","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jacc.2017.11.047","volume":"71","author":"P Menasch\u00e9","year":"2018","unstructured":"Menasch\u00e9 P, Vanneaux V, Hag\u00e8ge A, Bel A, Cholley B, Parouchev A, et al. Transplantation of human embryonic stem Cell\u2013Derived cardiovascular progenitors for severe ischemic left ventricular dysfunction. JACC. 2018;71(4):429\u201338.","journal-title":"JACC"},{"issue":"1","key":"4678_CR59","first-page":"e76770","volume":"17","author":"SA Ali","year":"2025","unstructured":"Ali SA, Mahmood Z, Mubarak Z, Asad M, Sarfraz Chaudhri MT, Bilal L, et al. Assessing the potential benefits of stem cell therapy in cardiac regeneration for patients with ischemic heart disease. Cureus. 2025;17(1):e76770.","journal-title":"Cureus"},{"issue":"12","key":"4678_CR60","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1161\/CIRCRESAHA.117.311080","volume":"120","author":"Y Yoshida","year":"2017","unstructured":"Yoshida Y, Yamanaka S. Induced pluripotent stem cells 10 years later. Circul Res. 2017;120(12):1958\u201368.","journal-title":"Circul Res"},{"key":"4678_CR61","doi-asserted-by":"publisher","first-page":"1324447","DOI":"10.3389\/fcvm.2024.1324447","volume":"11","author":"W Xiao","year":"2024","unstructured":"Xiao W, Shi J. Application of adipose-derived stem cells in ischemic heart disease: theory, potency, and advantage. Front Cardiovasc Med. 2024;11:1324447.","journal-title":"Front Cardiovasc Med"},{"key":"4678_CR62","doi-asserted-by":"publisher","first-page":"102909","DOI":"10.1016\/j.tice.2025.102909","volume":"95","author":"M Ribeiro","year":"2025","unstructured":"Ribeiro M. Advances in Cell-based therapies for peripheral arterial disease. Tissue Cell. 2025;95:102909.","journal-title":"Tissue Cell"},{"issue":"7","key":"4678_CR63","doi-asserted-by":"publisher","first-page":"602","DOI":"10.2174\/1574888X15666200324165655","volume":"15","author":"K Ji","year":"2020","unstructured":"Ji K, Ding L, Chen X, Dai Y, Sun F, Wu G, et al. Mesenchymal stem cells differentiation: mitochondria matter in osteogenesis or adipogenesis direction. Curr Stem Cell Res Ther. 2020;15(7):602\u20136.","journal-title":"Curr Stem Cell Res Ther"},{"key":"4678_CR64","doi-asserted-by":"publisher","first-page":"e1573403X376065","DOI":"10.2174\/011573403X376065250728094646","volume":"21","author":"S Nazir","year":"2025","unstructured":"Nazir S, Maqbool T, Savas S. Cardiac repair and mesenchymal stem cells: exploring new frontiers in regenerative medicine. Curr Cardiol Rev. 2025;21:e1573403X376065.","journal-title":"Curr Cardiol Rev"},{"issue":"1","key":"4678_CR65","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12951-025-03289-y","volume":"23","author":"Z Xu","year":"2025","unstructured":"Xu Z, Hong W, Mo Y, Shu F, Liu Y, Cheng Y, et al. Stem cells derived exosome laden oxygen generating hydrogel composites with good electrical conductivity for the tissue-repairing process of post-myocardial infarction. J Nanobiotechnol. 2025;23(1):213.","journal-title":"J Nanobiotechnol"},{"key":"4678_CR66","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pharmthera.2017.02.020","volume":"174","author":"L Barile","year":"2017","unstructured":"Barile L, Vassalli G, Exosomes. Therapy delivery tools and biomarkers of diseases. Pharmacol Ther. 2017;174:63\u201378.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"4678_CR67","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00381-022-05808-w","volume":"39","author":"EL Burnham","year":"2023","unstructured":"Burnham EL, Tomita T. Histogenesis of intracranial germ cell tumors: primordial germ cell vs. embryonic stem cell. Childs Nerv Syst. 2023;39(2):359\u201368.","journal-title":"Childs Nerv Syst"},{"issue":"10","key":"4678_CR68","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.4049\/jimmunol.2200042","volume":"208","author":"YL Guo","year":"2022","unstructured":"Guo YL, Gurung C, Fendereski M, Huang F. Dicer and PKR as novel regulators of embryonic stem cell fate and antiviral innate immunity. J Immunol. 2022;208(10):2259\u201366.","journal-title":"J Immunol"},{"issue":"7","key":"4678_CR69","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.ymthe.2018.05.009","volume":"26","author":"L Bagno","year":"2018","unstructured":"Bagno L, Hatzistergos KE, Balkan W, Hare JM. Mesenchymal stem Cell-Based therapy for cardiovascular disease: progress and challenges. Mol Ther. 2018;26(7):1610\u201323.","journal-title":"Mol Ther"},{"issue":"5","key":"4678_CR70","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3390\/biomedicines13051209","volume":"13","author":"NT Le","year":"2025","unstructured":"Le NT, Dunleavy MW, Zhou W, Bhatia SS, Kumar RD, Woo ST, et al. Stem cell therapy for myocardial infarction recovery: Advances, Challenges, and future directions. Biomedicines. 2025;13(5):1209.","journal-title":"Biomedicines"},{"key":"4678_CR71","doi-asserted-by":"publisher","first-page":"601560","DOI":"10.3389\/fbioe.2020.601560","volume":"8","author":"P Menasch\u00e9","year":"2020","unstructured":"Menasch\u00e9 P. Cell therapy with human ESC-Derived cardiac cells: clinical perspectives. Front Bioeng Biotechnol. 2020;8:601560.","journal-title":"Front Bioeng Biotechnol"},{"key":"4678_CR72","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/978-1-0716-2990-1_16","volume":"2631","author":"EC Bryda","year":"2023","unstructured":"Bryda EC, Men H, Stone BJ. Rat embryonic stem cell transgenesis. Methods Mol Biol. 2023;2631:355\u201370.","journal-title":"Methods Mol Biol"},{"issue":"4","key":"4678_CR73","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.7150\/thno.46119","volume":"11","author":"SJ Sun","year":"2021","unstructured":"Sun SJ, Lai WH, Jiang Y, Zhen Z, Wei R, Lian Q, et al. Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction. Theranostics. 2021;11(4):1641\u201354.","journal-title":"Theranostics"},{"issue":"10","key":"4678_CR74","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1080\/14712598.2023.2245329","volume":"23","author":"D Clavellina","year":"2023","unstructured":"Clavellina D, Balkan W, Hare JM. Stem cell therapy for acute myocardial infarction: mesenchymal stem cells and induced pluripotent stem cells. Expert Opin Biol Ther. 2023;23(10):951\u201367.","journal-title":"Expert Opin Biol Ther"},{"key":"4678_CR75","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.reth.2025.03.009","volume":"29","author":"H Izawa","year":"2025","unstructured":"Izawa H, Xiang C, Ogawa S, Hisanaga I, Yoshimoto T. Amelioration of female menopausal syndrome by intravenous administration of autologous menstrual blood-derived stem cells. Regen Ther. 2025;29:192\u2013201.","journal-title":"Regen Ther"},{"issue":"13","key":"4678_CR76","doi-asserted-by":"publisher","first-page":"6320","DOI":"10.3390\/ijms26136320","volume":"26","author":"C Ma","year":"2025","unstructured":"Ma C, Yu A, He T, Qian Y, Hu M. Stem cell therapy approaches for ischemia: assessing current innovations and future directions. Int J Mol Sci. 2025;26(13):6320.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4678_CR77","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3390\/ijms21020507","volume":"21","author":"AM Lodrini","year":"2020","unstructured":"Lodrini AM, Barile L, Rocchetti M, Altomare C. Human induced pluripotent stem cells derived from a cardiac somatic source: insights for an In-Vitro cardiomyocyte platform. Int J Mol Sci. 2020;21(2):507.","journal-title":"Int J Mol Sci"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04678-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04678-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04678-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T14:03:27Z","timestamp":1760018607000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04678-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4678"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04678-8","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"551"}}